Inhibitory effects of fluorinated benzenesulfonamides on insulin fibrillation

Saeid Hadi Alijanvand, Lucy Kate Ladefoged, Asta Zubrienė, Andrius Sakalauskas, Gunna Christiansen, Virginija Dudutiene, Birgit Schiøtt, Daumantas Matulis, Vytautas Smirnovas, Daniel E Otzen*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review


Amyloid fibrils are protein aggregates formed by protein assembly through cross β structures. Inhibition of amyloid fibril formation may contribute to therapy against amyloid-related disorders like Parkinson's, Alzheimer's, and type 2 diabetes. Here we report that several fluorinated sulfonamide compounds, previously shown to inhibit human carbonic anhydrase, also inhibit the fibrillation of different proteins. Using a range of spectroscopic, microscopic and chromatographic techniques, we found that the two fluorinated sulfonamide compounds completely inhibit insulin fibrillation over a period of 16 h and moderately suppress α-synuclein and Aβ fibrillation. In addition, these compounds decreased cell toxicity of insulin incubated under fibrillation-inducing conditions. We ascribe these effects to their ability to maintain insulin in the native monomeric state. Molecular dynamic simulations suggest that these compounds inhibit insulin self-association by interacting with residues at the dimer interface. This highlights the general anti-aggregative properties of aromatic sulfonamides and suggests that sulfonamide compounds which inhibit carbonic anhydrase activity may have potential as therapeutic agents against amyloid-related disorders.

TidsskriftInternational Journal of Biological Macromolecules
Sider (fra-til)590-600
Antal sider11
StatusUdgivet - feb. 2023


Dyk ned i forskningsemnerne om 'Inhibitory effects of fluorinated benzenesulfonamides on insulin fibrillation'. Sammen danner de et unikt fingeraftryk.